Identifying Non-Steroidal Anti-Inflammatory Drug (NSAID) Users Among People with Osteoarthritis Through Administrative and Clinician-Reported Data – A Validation Study of 116,162 Patients
DOI: https://doi.org/10.2147/CLEP.S401726
2023-06-16
Clinical Epidemiology
Abstract:Andrea Dell'Isola, Ali Kiadaliri, Clara Hellberg, Aleksandra Turkiewicz, Martin Englund Clinical Epidemiology Unit, Department of Clinical Sciences Lund, Orthopedics, Lund University, Lund, Sweden Correspondence: Andrea Dell'Isola, Email Purpose: (i) To report the prevalence of participants to a first-line intervention for OA in Sweden using over-the-counter (OTC) and/or prescribed NSAIDs; (ii) To estimate the accuracy of dispensed prescriptions of NSAIDs recorded in a Swedish health-care register to capture the use of NSAID considering clinician-report as reference standard. Methods: Register-based study. We used data from OA individuals who participated in the Swedish first-line intervention recorded in the Swedish Osteoarthritis Register (SOAR). SOAR includes clinician-reported use of NSAIDs in the three months preceding the intervention. We used the Prescribed Drug Register to retrieve data on NSAID prescriptions dispensed in the same period. We estimated the prevalence of OTC users (individuals with clinicians-reported use of NSAID but no prescription dispensed), prescription users (individuals with clinicians-reported use of NSAID and a prescription dispensed) and non-users (neither of the previous). We calculated sensitivity, specificity, positive predictive value, and negative predictive value of dispensed prescriptions of NSAIDs vs clinician-report. Results: We included 116,162 individuals (mean age [Standard Deviation]: 66 [9.6] years, 79% women, 77% knee OA). Overall, 24.7% (95% Confidence Intervals [CI] 24.5%; 25.0%) used OTC NSAIDs only, 18.2% (18.0%; 18.5%) used prescribed NSAIDs, 6.6% (6– 4%; 6.7%) reported not using NSAIDs while having an NSAID prescription dispensed. Of the 49,913 individuals with clinician-reported use of NSAIDs, 21,190 had a prescription dispensed (sensitivity: 42.5% [95% CI 42.0%, 42.9%]; positive predictive value: 73.5% [73.0%, 74.0%]). Of the 66,249 individuals reporting not using NSAIDs, 58,617 did not have a prescription dispensed (specificity: 88.5% [88.2%, 88.7%]; negative predictive value: 67.1% [66.8%, 67.4%]). Conclusion: Overall, 24.7% of participants in a first-line intervention for OA used OTC NSAIDs only while 18.2% used prescribed NSAIDs. Dispensed prescriptions of NSAIDs have high specificity but low sensitivity and can correctly identify about 70% of both the non-users and users in this population. Keywords: osteoarthritis, NSAID, register, validation Osteoarthritis (OA) affects more than 500 million people worldwide causing pain and disability. 1 In the last 30 years, the prevalence of OA has increased by nearly 50%, a trend that is expected to continue. 2 Without disease-modifying treatments, oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are the most used pharmaceutical for OA pain control and are at least conditionally recommended by clinical practice guidelines as second-line treatments for OA. 3,4 Still, NSAIDs are often preferred to first-line treatments – exercise, weight loss, and self-management – and are with opioids the most used treatment for OA in the US. 5 NSAIDs are considered safe at low doses and for brief treatment periods. Nevertheless, their use is associated with a significant health burden due to frequent adverse events. 6 Electronic medical records are important to study trends, side effects, and burden on society over long periods, which would otherwise be impossible in randomized controlled trials. However, many NSAIDs can be purchased over the counter (OTC) and are seldom recorded in health-care registers. A report from the 2011 five European countries (5EU) National Health and Wellness Survey (NHWS) suggested that 64% of people with OA report using NSAIDs, of which 17% use OTC-only and 9% use both. 7 Other reports using insurance records showed a similar prevalence of prescribed and OTC NSAIDs among analgesic users in France. 8 These results suggest that using prescribed NSAIDs may underestimate the proportion of real NSAID users, leading to the underestimation of the costs and burdens of these pharmaceuticals. The aims of this study are: (i) to report the prevalence of participants to a first-line intervention for OA in Sweden using OTC and/or prescribed NSAIDs; (ii) to estimate the accuracy of dispensed prescriptions of NSAIDs recorded in a Swedish health-care register to capture the use of NSAID considering clinician-report as reference standard. We conducted a study using data from two National Swedish registers. The Swedish Osteoarthritis Register (SOAR) contains data from persons with knee or hip OA, who have participated in a face-to-face first-line treatment offered in more than 500 different physical therapist units all over Sweden. 9 The Prescribed -Abstract Truncated-
public, environmental & occupational health